ST
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.044
Exchange
XLON - London Stock Exchange
2.582
Last period Debt / Equity ratio ,GBP
15938%
Debt / Equity ratio has increased in 5 years
What is Debt / Equity ratio ?
Debt / Equity ratio is the volume of debt obligations to the equity of the company. The value of 0.5 is the benchmark for Eyestock Rating calculation.
See also Shield Therapeutics
Company Analysis
STX.L valuation, rating, competitors, insights and company profile
Eyestock Rating
STX.L financial analysis by Eyestock methodology
Valuation
STX.L valuation using historical relative method
Statements
STX.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
STX.L dividend yield and annual dividend
Debt / Equity ratio is the volume of debt obligations to the equity of the company. The value of 0.5 is the benchmark for Eyestock Rating calculation.
Shield Therapeutics`s Debt / Equity ratio for the last twelve months ended 2024-06-30 is 2.582
